Intensive immunosuppression followed by autologous hematopoietic stem cell transplantation for the treatment of multiple sclerosis

Autologous hematopoietic stem cell transplantation (AHSCT) to treat multiple sclerosis (MS) has mostly been used in devastating cases as the last option to stop further neurological deterioration. However, evidence from several retrospective clinical trials indicates that young, less disabled patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Lycke, Jan, Lenhoff, Stig
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315665/
https://www.ncbi.nlm.nih.gov/pubmed/32636931
http://dx.doi.org/10.1177/1756286420929467

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315665/
https://www.ncbi.nlm.nih.gov/pubmed/32636931
http://dx.doi.org/10.1177/1756286420929467

Ejemplares similares